No misleading: TFA covers this. They did the thing you complain about in the second paragraph because of your complaint in the first paragraph. If you include

No misleading: TFA covers this. They did the thing you complain about in the second paragraph because of your complaint in the first paragraph. If you include ICU patients then you're biasing towards hydroxy experimental prescription that had bad outcomes. From MD friend: "Compassionate use" is a term of art that means "we gave it to em because we ran out of other options and family consented to the treatment with known downsides", so excluding ICU prevents a complaint that it's obviously biased because patients that were obviously more likely to die were also more likely to get hcq. MD friend also says you can't do randomized trials with known-toxic treatments, and the implicit "they took it versus didn't" is the control vs. placebo. Not randomizing doesn't mean there isn't any control vs. placebo, and not having a literal placebo pill biases the results to being positive for hydroxy. My takeaway is they stacked the deck for HCQ to prevent self-peasantization, and yet...